Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1633, 2008-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rosiglitazone: FDA must provide more than black box warning
Reactions Weekly, Vol. 1, Iss. 1314, 2010-01 ,pp. :
Media coverage on ADRs may do more harm than good
Reactions Weekly, Vol. 1, Iss. 1319, 2010-01 ,pp. :
Calcium supplements may do more harm than good
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
The US FDA `Black Box' Warning for Topical Calcineurin Inhibitors: An Ongoing Controversy
Drug Safety, Vol. 31, Iss. 3, 2008-01 ,pp. :